New Research Finds Value in PSA Testing
Tuesday, September 5, 2017
TUESDAY, Sept. 5, 2017 (HealthDay News) -- Despite ongoing debate over the value of prostate cancer screening, a new review says it can indeed reduce a man's risk of dying from the disease.
Early tumor detection using the prostate-specific antigen (PSA) blood test lowers a man's risk of prostate cancer death by 25 percent to 32 percent, the new analysis of two major trials of PSA testing found.
https://medlineplus.gov/news/fullstory_168199.html
